Issue Content

April 3, 2021
There is a growing need for temporary epicardial and transvenous cardiac pacing. A fully bioresorbable, leadless, battery-free cardiac pacemaker has the potential to be used for a limited amount of time as an alternative.
April 3, 2021
Included this month is a letter to the editor and response in regards to a recent EP Lab Digest article in the January 2021 issue.
April 3, 2021
Daniel Alyesh, MD, and colleagues describe the proposed pathophysiology of “long-hauler syndrome” and their experience with these patients.
April 3, 2021
EP Lab Digest speaks with Marshall Winner, MD, about the Atrial Fibrillation Center of Excellence at TriHealth Heart Institute in Cincinnati, Ohio.
April 3, 2021
Carol Wesley describes how a cost-benefit analysis can lead to a fundamental understanding of program needs vs wants as well as the costs vs benefits — a valuable exercise for any program seeking to make the most effective use of limited funds.
April 2, 2021
In this episode of The EP Edit podcast, we’re highlighting Great Debates & Updates in Electrophysiology, taking place online April 22-24th.
April 2, 2021
Roman Piotrowski, MD, and Piotr Kulakowski, MD, PhD, FESC present a patient with cardioinhibitory VVS treated successfully with cardioneuroablation.
April 2, 2021
Obayda Azizy, MD and colleagues investigate the impact of left atrial appendage closure on left atrial function in patients with paroxysmal atrial fibrillation.
April 2, 2021
EP Lab Digest speaks with Deepak Gaba, MD (Clinical Cardiac Electrophysiologist), and Shari Slyder, BS, RT(R) (CI) ARRT (Managing Director of Cardiovascular Services).
April 2, 2021
In this month’s issue, we talk with David M. Donaldson, MD, FACC, FHRS about this EP program in Orange, California.